Reaction

Congenital Pulmonary Valve Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 103 reports · 3 co-occurring drugs

As of the last recalculation, Congenital Pulmonary Valve Disorder appears in 103 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 224.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Zidovudine13224.7224.9
Darunavir12181.3181.5
Raltegravir12166.1166.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.